 HEIDELBERG, Germany, Aug. 23, 2021 GLOBE NEWSWIRE -- Affimed N.V. Nasdaq: AFMD, a clinical stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that it will release second quarter 2021 results on Wednesday, September 8, 2021, and host a conference call at 8:30 a.m. EDT to discuss financial results and recent corporate developments. 